Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
Baird Medical (NASDAQ: BDMD) participated in the 2024 American College of Surgeons Clinical Congress in San Francisco, showcasing its microwave ablation (MWA) technology to over 10,000 attendees, including 7,000 surgeons. At Booth 1061, the company demonstrated MWA applications for thyroid nodules, breast disease, liver cancer, and uterine fibroids. The technology, already adopted by institutions like Columbia University and Weill Cornell, attracted significant interest through hands-on simulations. Baird participated in panel discussions on ablative therapies and engaged with endocrine surgery leaders, reinforcing its commitment to market expansion.
Baird Medical (NASDAQ: BDMD) ha partecipato al Congresso Clinico 2024 dell'American College of Surgeons a San Francisco, presentando la sua tecnologia di ablazione a microonde (MWA) a oltre 10.000 partecipanti, tra cui 7.000 chirurghi. Allo Stand 1061, l'azienda ha dimostrato le applicazioni della MWA per noduli tiroidei, patologie mammarie, cancro al fegato e fibromi uterini. La tecnologia, già adottata da istituzioni come l'Università di Columbia e il Weill Cornell, ha suscitato un notevole interesse attraverso simulazioni pratiche. Baird ha partecipato a discussioni in panel sulle terapie ablative e ha interagito con leader della chirurgia endocrina, rafforzando il proprio impegno per l'espansione del mercato.
Baird Medical (NASDAQ: BDMD) participó en el Congreso Clínico 2024 del American College of Surgeons en San Francisco, mostrando su tecnología de ablación por microondas (MWA) a más de 10,000 asistentes, incluidos 7,000 cirujanos. En elstand 1061, la compañía demostró aplicaciones de MWA para nódulos tiroideos, enfermedades mamarias, cáncer de hígado y fibromas uterinos. La tecnología, ya adoptada por instituciones como la Universidad de Columbia y el Weill Cornell, atrajo un gran interés a través de simulaciones prácticas. Baird participó en discusiones en panel sobre terapias ablativas e interactuó con líderes en cirugía endocrina, reforzando su compromiso con la expansión del mercado.
Baird Medical (NASDAQ: BDMD)는 샌프란시스코에서 열린 2024년 미국 외과 의사 대학 임상 총회에 참여하여 마이크로웨이브 절제 (MWA) 기술을 10,000명 이상의 참석자, 그 중 7,000명의 외과 의사들에게 선보였습니다. 부스 1061에서 회사는 갑상선 결절, 유방 질환, 간암 및 자궁 섬유종에 대한 MWA 응용 프로그램을 시연했습니다. 컬럼비아 대학교와 와일 코넬과 같은 기관에서 이미 채택된 이 기술은 실습 시뮬레이션을 통해 상당한 관심을 끌었습니다. Baird는 절제 치료에 대한 패널 토의에 참여하고 내분비 수술 리더들과 소통하며 시장 확장에 대한 의지를 강화했습니다.
Baird Medical (NASDAQ: BDMD) a participé au Congrès Clinique 2024 de l'American College of Surgeons à San Francisco, présentant sa technologie d'ablation par micro-ondes (MWA) à plus de 10 000 participants, dont 7 000 chirurgiens. Au stand 1061, l'entreprise a démontré des applications de la MWA pour les nodules thyroïdiens, les maladies du sein, le cancer du foie et les fibromes utérins. La technologie, déjà adoptée par des institutions comme l'Université de Columbia et Weill Cornell, a suscité un intérêt considérable grâce à des simulations pratiques. Baird a participé à des discussions en panel sur les thérapies ablatives et a interagi avec des leaders de la chirurgie endocrinienne, renforçant son engagement envers l'expansion du marché.
Baird Medical (NASDAQ: BDMD) nahm am Klinikkongress 2024 des American College of Surgeons in San Francisco teil und präsentierte seine Mikrowellenablationstechnologie (MWA) vor über 10.000 Teilnehmern, darunter 7.000 Chirurgen. Am Stand 1061 demonstrierte das Unternehmen MWA-Anwendungen für Schilddrüsenknoten, Brustkrankheiten, Leberkrebs und Uterusmyome. Die Technologie, die bereits von Institutionen wie der Columbia University und Weill Cornell angenommen wurde, zog durch praktische Simulationen erhebliches Interesse auf sich. Baird beteiligte sich an Podiumsdiskussionen über ablative Therapien und interagierte mit führenden Chirurgen der Endokrinologie, was das Engagement für die Markterweiterung verstärkte.
- Technology adopted by prestigious institutions (Columbia University, Weill Cornell, Tulane University)
- Strong presence at major industry event with 10,000+ attendees
- Diverse application potential across multiple medical conditions
- None.
The ACS, established in 1913, is the world's largest and most influential organization for surgeons, boasting more than 90,000 members across 144 countries. The annual Clinical Congress serves as a key platform for discussing surgical advancements, exploring new technologies, and fostering collaboration within the medical community.
On October 20, Baird Medical showcased its cutting-edge microwave ablation devices at Booth 1061, highlighting their applications in treating thyroid nodules, breast disease, liver cancer, and uterine fibroids. Baird's innovative MWA technology, which has been adopted by top institutions such as
The live demonstrations of Baird's MWA technology were a standout feature of the exhibition. Surgeons from the
Throughout the congress, Baird Medical actively engaged with key thought leaders and participated in a range of panel discussions, including sessions on "Emerging Ablative Therapies for Breast Cancer" and "Endocrine Surgery." These panels provided valuable insights into the future of ablation techniques and reinforced the growing interest in minimally invasive solutions for various conditions.
A major highlight of the event was reuniting with prominent leaders in the field of endocrine surgery and interventional endocrinology from top institutions. These collaborative discussions further strengthened Baird's mission to enhance patient care through innovative technology and fostered ongoing relationships with experts who have been instrumental in advancing the use of MWA in clinical practice.
As the ACS Clinical Congress ended, Baird Medical reaffirmed its commitment to expanding its presence in the
About the ACS Clinical Congress
The American College of Surgeons (ACS) Clinical Congress is one of the world's largest gatherings of surgeons, dedicated to sharing advancements in surgical techniques and improving patient care. The congress brings together thousands of professionals from across the globe to exchange knowledge and foster collaborations that advance clinical practices.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-proudly-invited-to-showcase-microwave-ablation-technology-at-the-acs-clinical-congress-302285609.html
SOURCE Baird Medical LLC
FAQ
What did Baird Medical (BDMD) showcase at the 2024 ACS Clinical Congress?
Which major institutions have adopted Baird Medical's (BDMD) MWA technology?
How many attendees were present at the 2024 ACS Clinical Congress where BDMD presented?
